Kura Oncology is a biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer. Kura’s pipeline of small molecule drug candidates is designed to ...

Live audio webcasts will be available in the Investors section of Kura’s website at https://kuraoncology.com/, with archived replays available following all three events.

The latest Kura Oncology update keeps the analyst fair value anchor at 33.0, while the explicit price target tied to the FDA approved Komzifti story now sits at US$30, reflecting how the approval and ...

Wall Street expects a year-over-year decline in earnings on lower revenues when Kura Oncology (KURA) reports results for the ...

Kura Oncology, Inc., a clinical-stage biopharmaceutical company focused on precision cancer treatments, announced its participation in three upcoming investor conferences. Management will engage in ...